Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cortisporin-TC Otic Suspension is a combination medication used to treat superficial bacterial infections of the external auditory canal. It contains colistin sulfate and neomycin sulfate as antibacterial agents, hydrocortisone acetate to reduce inflammation, and thonzonium bromide to enhance the penetration of active ingredients by dispersing cellular debris and exudate. **Mechanism of Action**: Colistin sulfate disrupts bacterial cell membranes, neomycin sulfate inhibits protein synthesis, hydrocortisone acetate controls inflammation, and thonzonium bromide aids in tissue contact of the active ingredients[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydrocortisone acetate + thonzonium bromide + neomycin sulfate + colistin sulfate.